statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates...

Nuvation Bio Completes Acquisition of AnHeart Therapeutics

Investors eyeing a purchase of Nuvation Bio Inc (NUVB) shares, but tentative about paying the going market price of 3.50/share, might benefit from considering selling puts among the alternative...

Commit To Buy Nuvation Bio At $2.50, Earn 17.2% Annualized Using Options

Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate...

Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate

BTIG Research upgraded shares of Nuvation Bio (NYSE:NUVB - Free Report) from a neutral rating to a buy rating in a research note published on Tuesday, MarketBeat reports. The firm currently has $5.00...

Nuvation Bio (NYSE:NUVB) Raised to Buy at BTIG Research

Nuvation Bio (NYSE:NUVB  Get Free Report) was upgraded by equities research analysts at Jefferies Financial Group from a hold rating to a buy rating in a research...

Nuvation Bio (NYSE:NUVB) Rating Increased to Buy at Jefferies Financial Group

Nuvation Bio Inc. (NYSE:NUVB  Free Report)  Wedbush issued their Q1 2025 earnings per share estimates for Nuvation Bio in a research note issued on Monday, March 25th. Wedbush...

Nuvation Bio Inc. Forecasted to Earn Q1 2025 Earnings of ($0.10) Per Share (NYSE:NUVB)

Nuvation Bio Inc. (NYSE:NUVB  Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $2.65 and last traded at $2.63, with a volume of 656006 shares...

Nuvation Bio (NYSE:NUVB) Reaches New 1-Year High at $2.65

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Nuvation Bio price target raised by $3 at H.C. Wainwright, here's why

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Volume	1.96M
52-Wk High	$4.16
52-Wk Low	$0.95

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.09	--	--	N/A
Q4'23	-$0.10	-$0.06	39.58%	BEAT
Q3'23	-$0.11	-$0.09	14.29%	BEAT
Q2'23	-$0.11	-$0.09	19.83%	BEAT
Q1'23	-$0.10	-$0.10	0.05%	BEAT

NUVB Nuvation Bio Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals